Dermapharm rises on H1 beat

Dermapharm Holding SE

16/08/2023 07:58

** Dermapharm  DMPG.DE  shares rise 4% in early Frankfurt
trade after the drugmaker reported its H1 results above
estimates
    ** The company reported H1 adjusted EBITDA of 168 million
euros ($183.51 million), above consensus of 163 million euros
according to Pareto securities
    ** The company added it expected to hit the upper range of
its FY outlook
    ** "In our view, the strong H1 performance puts the company
well on track to achieve its reiterated FY’23 guidance of
revenues between EUR 1,080m and EUR 1,110m and adjusted EBITDA
of between EUR 300m and EUR 310m" Pareto securities says
    ** Dermapharm tops Germany's small caps index  .SDAXI  in
early Frankfurt trade


($1 = 0.9155 euros)

 (Reporting by Tristan Veyet)
 ((Tristan.chabba@thomsonreuters.com))